This Biotech Stock Is Surging Over Potential COVID-19 Drug

Regeneron is speeding up the development of a therapy against COVID-19. Investors welcomed the news by bidding up company stock. The post This Biotech Stock Is Surging Over Potential COVID-19 Drug appeared first on CCN.com дальше »